Increasing physical activity improves survival in lymphoma patients, researchers say

December 11, 2017, Mayo Clinic

An observational study by researchers at Mayo Clinic has found that increasing physical activity not only decreased the risk of death from all causes but also decreased the risk of death specifically from lymphoma. Lymphoma is a cancer of the lymphatic system, the part of the body's germ-fighting network which includes the lymph nodes (lymph glands), spleen, thymus gland and bone marrow. Lymphoma can affect those areas as well as other organs throughout the body. Study results were presented today at the 59th American Society of Hematology annual meeting in Atlanta by Priyanka Pophali, M.B.B.S., a hematologist at Mayo Clinic.

"As physicians, we recommend for all cancer survivors to improve overall quality of life," says Dr. Pophali. "But we did not know if physical activity would have an impact on survival in patients."

Dr. Pophali and her colleagues wanted to assess how physical activity affected survival in all subtypes of both before and after diagnosis. Specifically, they wanted to know if changing the level of a lymphoma patient's physical activity after diagnosis could affect survival."

In order to answer these questions, researchers studied a cohort of 4087 lymphoma patients enrolled prospectively (within 9 months of diagnosis) at Mayo Clinic between 2002 and 2012. At enrollment, participants completed questionnaires that asked about their usual physical activity before their lymphoma diagnosis. Researchers regularly contacted patients to collect information on exposures and outcomes and contacted them for a three-year follow-up. Researchers used this information to calculate a Godin Leisure Score Index, a physical activity score which is a validated tool for measuring physical activity in oncology patients. Patients were also asked about their perception of any change in their level of physical activity (increase, decrease or no change) at three years after their diagnosis compared to baseline. Researchers then evaluated the association of physical activity with overall and lymphoma-specific survival.

Researchers found that patients who had a higher level of usual adult physical activity prior to a lymphoma diagnosis had significantly better overall and lymphoma-specific survival compared to those who were less physically active. They also found that patients who increased their level of physical activity after their lymphoma diagnosis (at three-year follow-up) had significantly better overall and lymphoma-specific survival compared to those who were less physically active.

Researchers found that patients who perceived that their level of physical activity had decreased at three years after a lymphoma had worse overall and lymphoma-specific survival compared to those who did not report a change.

"Our findings show that physical activity can have a positive impact on survival in lymphoma patients," says Dr. Pophali. "Importantly, our study shows a survival benefit in patients who increase their level of physical activity. Therefore, since physical activity behaviors can be modified, physicians should counsel and survivors on the importance of physical activity and encourage them to maintain and, if possible, increase their level of physical activity."

Explore further: Decreased physical activity common after cancer diagnosis

Related Stories

Decreased physical activity common after cancer diagnosis

January 25, 2017
(HealthDay)—Exercise can help cancer patients cope with their treatment, but as many as 75 percent reduce their physical activity after diagnosis, according to a study presented at the American Society of Clinical Oncology's ...

Lifetime intense physical activity may lower risk for non-Hodgkin lymphoma

May 1, 2015
Performing vigorous physical activity over one's lifetime may lower risk for non-Hodgkin lymphoma (NHL). These study results were published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association ...

Having HIV and chronic HBV/HCV coinfection may increase cancer risk

October 17, 2016
In HIV-infected patients receiving antiretroviral therapy (ART), chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is associated with an increased risk for non-Hodgkin's lymphoma. The findings are published ...

HIV-associated lymphoma survival has not improved during the antiretroviral therapy era

July 27, 2013
Stable survival rates were observed for HIV-associated lymphoma patients during the antiretroviral therapy (ART) era in the US, according to a new study published July 26 in the Journal of the National Cancer Institute.

Study shows inferior outcomes for African-American pediatric lymphoma patients

January 22, 2016
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine (Sylvester) today published a study showing that African-American pediatric Hodgkin lymphoma patients have inferior ...

Two-thirds of bowel cancer patients aren't advised to exercise despite health benefits

April 28, 2015
More than two-thirds (69 per cent) of bowel cancer patients say they weren't advised to exercise regularly after their diagnosis - despite evidence that brisk physical activity is linked to better survival in bowel cancer, ...

Recommended for you

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

New test could tell doctors whether patients will respond to chemotherapy

April 24, 2018
Less than half the patients diagnosed with cancer respond favorably to chemotherapy, but a new method for testing how patients will respond to various drugs could pave the way for more personalized treatment.

Scientists create better laboratory tools to study cancer's spread

April 23, 2018
Cancer that has spread, or metastasized, from its original site to other tissues and organs in the body is a leading cause of cancer death. Unfortunately, research focused on metastatic disease has been limited by a lack ...

The role of 'extra' DNA in cancer evolution and therapy resistance

April 23, 2018
Glioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is poor, with a two-year survival rate of only 15 percent. Research is beginning to provide a better understanding ...

Size, structure help poziotinib pose threat to deadly exon 20 lung cancer

April 23, 2018
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease, researchers at The University of Texas MD Anderson Cancer ...

How to hijack degrading complexes to put cancer cells asleep

April 23, 2018
Newcastle and Dundee University researchers have uncovered an alternative path of how the breast cancer drug palbociclib drives malignant cells into cell death, senescence.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.